ArticleFrontiers in immunology2019

High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia.

Stephan Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.